Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-16 Sale |
2025-01-17 7:20 pm |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
8,470 | $0.58 | $4,913 | 508,893 (Direct) |
View |
| 2025-01-15 Sale |
2025-01-16 5:23 pm |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
2,331 | $0.63 | $1,469 | 115,280 (Direct) |
View |
| 2025-01-14 Sale |
2025-01-15 9:17 pm |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
3,713 | $0.66 | $2,451 | 125,111 (Direct) |
View |
| 2024-10-02 Sale |
2024-10-07 5:48 pm |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
13,687 | $1.9836 | $27,150 | 94,824 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 5:18 pm |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
9,327 | $2.71 | $25,276 | 424,094 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:12 pm |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, Chief Financial Officer |
5,131 | $5.74 | $29,452 | 287,989 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-15 Option Award |
2025-01-17 7:20 pm |
N/A 2035-01-14 |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
343,750 | $0 | 508,893 (Direct) |
View |
| 2025-01-15 Exercise |
2025-01-17 7:20 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
20,833 | $0 | 508,893 (Direct) |
View |
| 2025-01-14 Exercise |
2025-01-16 5:23 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
6,250 | $0 | 115,280 (Direct) |
View |
| 2025-01-13 Exercise |
2025-01-15 9:17 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
10,000 | $0 | 125,111 (Direct) |
View |
| 2024-10-01 Exercise |
2024-10-07 5:48 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
50,000 | $0 | 94,824 (Direct) |
View |
| 2024-01-15 Option Award |
2024-01-17 5:18 pm |
N/A 2034-01-14 |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
320,833 | $0 | 424,094 (Direct) |
View |
| 2024-01-13 Exercise |
2024-01-17 5:18 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO & CFO |
26,458 | $0 | 424,094 (Direct) |
View |
| 2023-09-05 Option Award |
2023-09-07 5:51 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, COO and CFO |
50,000 | $0 | 50,000 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:12 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, Chief Financial Officer |
220,000 | $0 | 287,989 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:12 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, Chief Financial Officer |
16,458 | $0 | 287,989 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 5:45 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian Chief Financial Officer |
137,500 | $0 | 181,739 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 5:45 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian Chief Financial Officer |
20,416 | $0 | 181,739 (Direct) |
View |
| 2021-01-15 Tax Withholding |
2021-01-20 7:04 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian Sr. VP., FIN, Product Strategy |
1,162 | $21.09 | 155,797 (Direct) |
View |
| 2021-01-15 Option Award |
2021-01-20 7:04 pm |
N/A 2031-01-15 |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian Sr. VP., FIN, Product Strategy |
137,500 | $0 | 155,797 (Direct) |
View |
| 2021-01-15 Exercise |
2021-01-20 7:04 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian Sr. VP., FIN, Product Strategy |
3,959 | $0 | 155,797 (Direct) |
View |